Oceania Healthcare (ASX:OCA) - CEO, Brent Pattison
CEO, Brent Pattison
Source: Oceania Healthcare
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Oceania Healthcare (OCA) has closed its non-underwritten, NZ$20 million (roughly A$18.49 million) retail offer oversubscribed
  • The retail offer was well supported by shareholders, with Oceania receiving applications totalling around NZ$50 million (around A$42.2 million)
  • The new shares will be issued at NZ$1.27 (about A$1.17), a 2.5 per cent discount to the five-day volume-weighted average market price of Oceania shares
  • Settlement of the offer is expected to occur tomorrow
  • Oceania Healthcare shares last traded at $1.21 cents on April 14

Oceania Healthcare (OCA) has closed its non-underwritten retail offer oversubscribed.

Oceania Healthcare is a leading provider of healthcare services in New Zealand.

The NZ$20 million (approximately A$18.49 million) offer was well supported by shareholders, with Oceania receiving applications totalling around NZ$50 million (around A$42.2 million). Scaling and the return of any surplus application amounts will be carried out in accordance with the terms of the retail offer.  

The offer was part of Oceania’s equity raising, under which Oceania also undertook a fully underwritten NZ$80 million (roughly A$74 million) placement of new shares to institutional shareholders in New Zealand, Australia and other jurisdictions.

Under the retail offer, eligible existing shareholders could each subscribe for up to NZ$50,000 (around A$46,220) worth of new Oceania shares. Over 5,000 Oceania shareholders applied under the retail offer, with an average application size of NZ$9,600 (approximately A$8,894).

The new shares will be issued at NZ$1.27 (approximately A$1.17), a 2.5 per cent discount to the five-day volume-weighted average market price of Oceania shares.

Settlement of the offer is expected to occur tomorrow, with new shares ranking equally in all respects to existing ordinary shares.

Oceania Healthcare shares last traded at $1.21 cents on April 14.

OCA by the numbers
More From The Market Online

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Recce wins safety board approval to dose 4g in R327 UTI infusion trial

Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…